139 related articles for article (PubMed ID: 16613813)
1. Reassessment of combined LT4 and LT3 treatment for hypothyroidism: the prospects for slow-release T3 preparations.
Duntas LH
Hormones (Athens); 2005; 4(2):108-10. PubMed ID: 16613813
[No Abstract] [Full Text] [Related]
2. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.
Appelhof BC; Fliers E; Wekking EM; Schene AH; Huyser J; Tijssen JG; Endert E; van Weert HC; Wiersinga WM
J Clin Endocrinol Metab; 2005 May; 90(5):2666-74. PubMed ID: 15705921
[TBL] [Abstract][Full Text] [Related]
3. ITALIAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS STATEMENT-REPLACEMENT THERAPY FOR PRIMARY HYPOTHYROIDISM: A BRIEF GUIDE FOR CLINICAL PRACTICE.
Guglielmi R; Frasoldati A; Zini M; Grimaldi F; Gharib H; Garber JR; Papini E
Endocr Pract; 2016 Nov; 22(11):1319-1326. PubMed ID: 27482609
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.
Van Tassell B; Wohlford GF; Linderman JD; Smith S; Yavuz S; Pucino F; Celi FS
Thyroid; 2019 Oct; 29(10):1371-1379. PubMed ID: 31364488
[No Abstract] [Full Text] [Related]
5. The effects of combination treatment with LT4 and LT3 on diastolic functions and atrial conduction time in LT4-treated women with low T3: a short term follow-up study.
Buber I; Eraydin A; Sevgican CI; Tekin I; Kilic ID; Fenkci SM
Endocrine; 2023 Aug; 81(2):316-321. PubMed ID: 37074560
[TBL] [Abstract][Full Text] [Related]
6. Use of thyroid hormones in hypothyroid and euthyroid patients: A 2020 THESIS questionnaire survey of members of the Danish Endocrine Society.
Riis KR; Frølich JS; Hegedüs L; Negro R; Attanasio R; Nagy EV; Papini E; Perros P; Bonnema SJ
J Endocrinol Invest; 2021 Nov; 44(11):2435-2444. PubMed ID: 33774809
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of hypothyroidism. T4 or better T3/T4?].
Meng W
MMW Fortschr Med; 2000 Apr; 142(15):39-40. PubMed ID: 10842475
[No Abstract] [Full Text] [Related]
8. Combined T4 and T3 therapy.
Utiger RD
Thyroid; 2004 Oct; 14(10):872. PubMed ID: 15588389
[No Abstract] [Full Text] [Related]
9. Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design.
Premawardhana LD; Taylor PN; Okosieme OE; Adlan MA; Obuobie EK; Dayan CM
Front Endocrinol (Lausanne); 2023; 14():1282608. PubMed ID: 38034018
[TBL] [Abstract][Full Text] [Related]
10. Current evidence for the treatment of hypothyroidism with levothyroxine/levotriiodothyronine combination therapy versus levothyroxine monotherapy.
Hennessey JV; Espaillat R
Int J Clin Pract; 2018 Feb; 72(2):. PubMed ID: 29381251
[TBL] [Abstract][Full Text] [Related]
11. L-T4 and L-T3 combined treatment vs L-T4 alone.
Wiersinga WM
Ann Endocrinol (Paris); 2007 Sep; 68(4):216-9. PubMed ID: 17689474
[No Abstract] [Full Text] [Related]
12. Benefits and Harms of Levothyroxine/L-Triiodothyronine Versus Levothyroxine Monotherapy for Adult Patients with Hypothyroidism: Systematic Review and Meta-Analysis.
Millan-Alanis JM; González-González JG; Flores-Rodríguez A; Singh Ospina N; Maraka S; Moreno-Peña PJ; Brito JP; González-Velázquez C; Rodríguez-Gutiérrez R
Thyroid; 2021 Nov; 31(11):1613-1625. PubMed ID: 34340589
[No Abstract] [Full Text] [Related]
13. Dosage recommendations for combination regimen of thyroxine and 3,5,3'-triiodothyronine.
Blanchard KR
J Clin Endocrinol Metab; 2004 Mar; 89(3):1486-7; author reply 1487-8. PubMed ID: 15001655
[No Abstract] [Full Text] [Related]
14. [Development of hypothyroidism therapy with thyroid hormone].
Fang L; Tan T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Apr; 22(2):396-9. PubMed ID: 15884564
[TBL] [Abstract][Full Text] [Related]
15. Extended Absorption of Liothyronine from Poly-Zinc-Liothyronine: Results from a Phase 1, Double-Blind, Randomized, and Controlled Study in Humans.
Dumitrescu AM; Hanlon EC; Arosemena M; Duchon O; Ettleson M; Giurcanu M; Bianco AC
Thyroid; 2022 Feb; 32(2):196-205. PubMed ID: 34641706
[No Abstract] [Full Text] [Related]
16. Design of the Optimal Trial of Combination Therapy.
Cappola AR
Front Endocrinol (Lausanne); 2020; 11():168. PubMed ID: 32318021
[TBL] [Abstract][Full Text] [Related]
17. Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease.
Bunevicius R; Jakuboniene N; Jurkevicius R; Cernicat J; Lasas L; Prange AJ
Endocrine; 2002 Jul; 18(2):129-33. PubMed ID: 12374459
[TBL] [Abstract][Full Text] [Related]
18. Effects of either LT4 monotherapy or LT4/LT3 combined therapy in patients totally thyroidectomized for thyroid cancer.
Regalbuto C; Maiorana R; Alagona C; Paola RD; Cianci M; Alagona G; Sapienza S; Squatrito S; Pezzino V
Thyroid; 2007 Apr; 17(4):323-31. PubMed ID: 17465862
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy with levothyroxine and liothyronine for hypothyroidism.
Fischman A; Domínguez JM
Medwave; 2018 Dec; 18(8):e7376. PubMed ID: 30550536
[TBL] [Abstract][Full Text] [Related]
20. Physician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics.
Jonklaas J; Tefera E; Shara N
Thyroid; 2018 Nov; 28(11):1416-1424. PubMed ID: 30289349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
